Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effects of Dry Needling in Athletes With Subacromial Pain Syndrome

3 giugno 2026 aggiornato da: Carlos Alberto Villarón Casales, Universidad Europea de Valencia

Effects of Dry Needling on Proprioception, Dynamic Stability, Strength, Pain Perception, and Disability in Athletes With Subacromial Pain Syndrome

The goal of this clinical trial is to evaluate whether dry needling combined with therapeutic exercise improves shoulder proprioception in amateur athletes with subacromial pain syndrome. The study will also assess its effects on dynamic stability, strength, pain, and functional disability.

The main questions this study aims to answer are:

Does dry needling improve shoulder proprioception compared with therapeutic exercise alone? Does dry needling improve dynamic shoulder stability and muscle strength? Does dry needling reduce pain and upper limb disability?

Researchers will compare a group receiving dry needling plus therapeutic exercise with a group performing therapeutic exercise alone to determine whether the combined intervention produces better outcomes.

Participants will:

Be randomly assigned to one of the two treatment groups. Perform a home-based therapeutic exercise program for 3 weeks. Complete assessments of proprioception, dynamic stability, strength, pain, and functional disability before and after the intervention.

Panoramica dello studio

Stato

Non ancora reclutamento

Descrizione dettagliata

Subacromial pain syndrome (SAPS) is one of the most common causes of shoulder pain and dysfunction in both the general population and athletes involved in repetitive upper-limb activities. In sports requiring overhead movements, throwing actions, or repetitive shoulder loading, the increased mechanical demand placed on the glenohumeral joint may contribute to functional impairments, persistent pain, and reduced athletic performance.

Several studies have reported proprioceptive deficits and sensorimotor control alterations in individuals with SAPS. These impairments may affect joint position sense, muscular coordination, and dynamic shoulder stability, potentially contributing to symptom persistence and increasing the risk of recurrent injury. Previous research has also associated proprioceptive deficits with higher pain intensity, functional disability, and reduced neuromuscular control.

Proprioception plays a fundamental role in sensory integration and in the regulation of precise and coordinated shoulder movements. Altered afferent input from muscular and articular structures may impair dynamic stabilization mechanisms and compromise upper-limb function during sports activities.

Dry needling is a minimally invasive physiotherapy technique widely used for the treatment of myofascial trigger points. Previous studies have demonstrated positive effects of dry needling on pain and functional disability in individuals with subacromial pain syndrome. In addition, research conducted in other joints has suggested that dry needling may influence motor control, postural stability, and proprioceptive mechanisms.

Despite the growing clinical interest in this intervention, there is currently limited evidence regarding the effects of dry needling on shoulder proprioception and sensorimotor variables in individuals with SAPS, particularly in athletic populations. Therefore, further investigation is needed to determine whether adding dry needling to a therapeutic exercise program may provide additional benefits for neuromuscular control and shoulder function.

The primary aim of this clinical trial is to evaluate the effectiveness of dry needling combined with therapeutic exercise on shoulder proprioception in amateur athletes with subacromial pain syndrome. Additionally, the study will assess the potential effects of the intervention on dynamic stability, shoulder isometric strength, pain perception, and upper-limb functional disability.

A randomized controlled trial with two parallel groups will be conducted. Participants will be randomly assigned in a 1:1 ratio to:

an experimental group receiving dry needling combined with therapeutic exercise, or a control group receiving therapeutic exercise alone.

The intervention period will last 3 weeks. Participants in the experimental group will receive two dry needling sessions separated by a 10-day interval. The technique will be administered by an experienced physiotherapist with specialized training in dry needling, following a predefined protocol based on the available scientific literature.

The intervention will target myofascial trigger points located in scapulohumeral muscles commonly associated with shoulder pain and subacromial pain syndrome. Trigger points will be identified through standardized clinical examination procedures.

Both groups will perform a structured home-based therapeutic exercise program focused on muscular strengthening, neuromuscular control, and shoulder function. Participants will receive individualized instructions, and adherence to the exercise program will be monitored using follow-up records.

Outcome assessments will be performed by an evaluator blinded to group allocation in order to minimize measurement bias. Measurements will be collected at three time points: baseline, 10 days after the first intervention session, and 10 days after the second intervention session, to evaluate changes in proprioception, dynamic stability, muscular strength, pain, and functional disability.

This study aims to provide clinical evidence regarding the potential role of dry needling as an adjunct to therapeutic exercise in the management of sensorimotor and functional impairments associated with subacromial pain syndrome in athletic populations. The findings may contribute to the development of more effective therapeutic strategies aimed at improving shoulder function and optimizing functional recovery in athletes with this condition.

Tipo di studio

Interventistico

Iscrizione (Stimato)

40

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

Backup dei contatti dello studio

Luoghi di studio

    • Valencia
      • Valencia, Valencia, Spagna, 46006
        • Clínica Dr Villarón
        • Contatto:
        • Investigatore principale:
          • Carlos A Villarón Casales, PT, MSc, PhD
        • Sub-investigatore:
          • Pablo Taberner Mortes, PT, MSc
        • Sub-investigatore:
          • Alejandro Sendín Magdalena, PT, MSc, PhD
        • Sub-investigatore:
          • Mathilde Conde Aparicio, PT, MSc
        • Sub-investigatore:
          • Lucia Ortega Pérez de Villar, PT, MSc, PhD
        • Sub-investigatore:
          • Javier Fenollar Cortes, PT, MSc, PhD
        • Contatto:
          • Carlos A Villarón Casales, Clin. Dir.
          • Numero di telefono: + 34 611 68 62 26
          • Email: cvillaron@gmail.com

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Men and women aged between 18 and 40 years.
  • Clinical diagnosis of subacromial pain syndrome (SAPS) according to the Dutch Orthopaedic Association criteria: presence of a painful arc and at least two positive tests among the following: Hawkins-Kennedy test, Neer sign, Jobe test, Drop Arm test, or Gerber test.
  • Participation in sports involving predominant upper-limb activity between 2 and 4 hours per week.

Exclusion Criteria:

  • Previous surgery involving the upper extremities.
  • Diagnosis of specific shoulder pathologies other than SAPS at the time of the study.
  • Receipt of medical or physiotherapy treatment within the month prior to the intervention.
  • Needle phobia or refusal to receive dry needling treatment.
  • Presence of vestibular disorders, balance impairments, or vascular alterations that could interfere with study measurements.
  • Confirmed or suspected pregnancy.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Dry needling + therapeutic exercise
Participants assigned to the experimental group will receive a combined intervention consisting of dry needling and a structured home-based therapeutic exercise program over a 3-week period. Dry needling will be applied to active myofascial trigger points in scapulohumeral muscles commonly associated with subacromial pain syndrome, including the supraspinatus, infraspinatus, subscapularis, teres minor, teres major, and anterior and middle deltoid muscles. Trigger points will be identified through standardized clinical examination based on the presence of a palpable taut band, a hypersensitive spot, reproduction of recognizable pain, and local twitch response. The intervention will be performed by a physiotherapist with more than 10 years of experience and certified training in dry needling, using a fast in-fast out technique with sterile disposable needles after skin disinfection with chlorhexidine.
Dry needling will be applied to active myofascial trigger points identified in scapulohumeral muscles commonly associated with subacromial pain syndrome, including supraspinatus, infraspinatus, subscapularis, teres minor, teres major, and anterior and middle deltoid muscles. Trigger points will be identified through standardized clinical examination. The intervention will be performed by an experienced physiotherapist using sterile disposable needles and a standardized fast in-fast out technique. Participants will receive two dry needling sessions separated by a 10-day interval.
Participants will perform a structured home-based therapeutic exercise program focused on shoulder strengthening, neuromuscular control, and sensorimotor function using elastic resistance bands. The exercise program will be performed three times per week for 3 weeks following a standardized protocol. Participants will receive individualized instruction, exercise materials, and adherence monitoring throughout the intervention period.
Comparatore attivo: Therapeutic exercise
Participants assigned to the control group will receive a structured home-based therapeutic exercise program over a 3-week period without dry needling intervention. The exercise program will focus on shoulder strengthening, neuromuscular control, and sensorimotor function using elastic resistance bands. Participants will perform the exercises three times per week for 3 weeks following a standardized protocol. All participants will receive individualized in-person instruction from a physiotherapist to ensure correct exercise execution. Participants will also receive the necessary exercise materials and an adherence diary to record compliance throughout the intervention period. The therapeutic exercise program will be identical to the experimental group in terms of exercise type, frequency, duration, supervision, and home-based format.
Participants will perform a structured home-based therapeutic exercise program focused on shoulder strengthening, neuromuscular control, and sensorimotor function using elastic resistance bands. The exercise program will be performed three times per week for 3 weeks following a standardized protocol. Participants will receive individualized instruction, exercise materials, and adherence monitoring throughout the intervention period.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Shoulder Proprioception Assessed With the Joint Position Sense Test
Lasso di tempo: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Shoulder proprioception will be evaluated using the Joint Position Sense (JPS) test. Participants will actively reproduce a predefined shoulder position (abduction at 60°), and the absolute angular repositioning error in degrees will be recorded using an inclinometer. Scores range from 0 degrees (perfect repositioning) to no defined upper limit, with lower values indicating better proprioceptive accuracy.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Pain Intensity Assessed With the Numeric Rating Scale
Lasso di tempo: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Pain intensity will be assessed using the Numeric Rating Scale (NRS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Lower scores indicate lower pain intensity.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Dynamic Shoulder Stability Assessed With the Upper Quarter Y Balance Test
Lasso di tempo: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Dynamic shoulder stability will be assessed using the Upper Quarter Y Balance Test (YBT-UQ). Reach distances in the medial, inferolateral, and superolateral directions will be recorded in centimeters, with a minimum score of 0 cm and no predefined upper limit. Greater reach distance indicates better dynamic stability and sensorimotor performance.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Isometric Shoulder Strength Assessed With Handheld Dynamometry
Lasso di tempo: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Isometric strength of the shoulder abductors and rotator muscles will be measured using a handheld dynamometer during maximal voluntary isometric contractions. Force values are recorded in Newtons, with a minimum of 0 N and no predefined upper limit. Higher force values indicate greater muscle strength.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Upper Limb Disability Assessed With the Disabilities of the Arm, Shoulder and Hand Questionnaire
Lasso di tempo: Baseline, 10 days after the first intervention session, and 10 days after the second intervention session
Functional disability of the upper limb will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, scored from 0 to 100, where 0 indicates no disability and 100 indicates maximum disability. Higher scores indicate greater disability and functional impairment.
Baseline, 10 days after the first intervention session, and 10 days after the second intervention session

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Investigatori

  • Investigatore principale: Carlos A Villaron Casales, PT, MSc, PhD, Universidad Europea de Valencia

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Pubblicazioni generali

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

1 giugno 2026

Completamento primario (Stimato)

1 marzo 2027

Completamento dello studio (Stimato)

1 marzo 2027

Date di iscrizione allo studio

Primo inviato

27 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

27 maggio 2026

Primo Inserito (Effettivo)

2 giugno 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

5 giugno 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

3 giugno 2026

Ultimo verificato

1 giugno 2026

Maggiori informazioni

Termini relativi a questo studio

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data will not be shared due to ethical and data protection constraints under Spanish and European regulations (RGPD, Ley Orgánica 3/2018). Anonymized aggregate results will be made available through publication in peer-reviewed journals

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi